Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnancy After Stem Cell Transplantation in POF
NCT02151890Phase 2
Key facts
- Status
- Completed
- Start
- Mar 2012
- Primary completion
- May 2014
- Countries
- 1
- Sponsor
- Al-Azhar University
- Modality
- Stem Cell Therapies
- Conditions
- primary ovarian insufficiency (POI)
01
Overview
Phase 2, open-label, single-arm trial of autologous mesenchymal stem cells in primary ovarian insufficiency (POI), sponsored by Al-Azhar University. Primary endpoint: Pregnancy at 104 weeks. Started Mar 2012; status: completed.
02
Design
1 arm- Study design
- Non-randomizedOpen-labelSingle group
Laparoscopic Stem Cell Transplantation
Single arm receiving laparoscopic injection of autologous stem cells
03
Endpoints
Primary
Pregnancy
Secondary
Menstruation
Beyond the preview
Go deeper on NCT02151890.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02151890.